查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1880601

家禽疫苗市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032 年）

Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

家禽疫苗市場成長推動因素

受家禽產品需求成長、傳染病發病率上升以及家禽群健康管理意識增強的推動，全球家禽疫苗市場正經歷顯著增長。預計 2024 年市場規模將達到 12.7 億美元，2025 年將達到 13.2 億美元，到 2032 年將成長至 20.1 億美元，在預測期內維持 6.13% 的穩定複合年增長率。由於嚴格的監管、先進的獸醫基礎設施以及主要行業參與者的存在，北美在2024年佔了45.66%的市場佔有率，成為市場主導者。

全球禽蛋和禽肉消費量的成長是市場成長的主要推動力。根據美國農業部預測，2024/2025年度美國雞肉產量預計將達到2,134萬噸，約佔全球產量的21.0%。維持如此高的產量需要維持禽群健康，以確保食品安全、穩定供應和優質蛋白質來源。疫苗接種是預防禽流感、新城疫、馬立克氏症和傳染性支氣管炎等疾病爆發的重要手段，能保障經濟效益及禽類生產力。 2024年11月，Vaxxinova公司獲得歐盟委員會對其新城疫病毒疫苗Vaxxon ND Clone的上市許可，顯示該公司積極推廣有效免疫接種。 市場推動因素與阻礙因素 家禽消費量的增長以及養殖戶生物安全意識的提高，為該市場提供了強有力的支撐。疫苗接種不僅可以減少經濟損失，還能提高家禽養殖場的整體健康狀況和生產力。此外，Zoetis Services LLC、Merck & Co., Inc.和Boehringer Ingelheim International GmbH等主要公司正大力投資研發，以開發更有效、更經濟的疫苗。這些策略舉措進一步推動了市場擴張。 然而，全球家禽疫苗市場也面臨挑戰。疫苗失效和 "洩漏" 的風險限制了市場成長。家禽病原體（例如馬立克氏症和禽流感）的高變異率會降低疫苗效力，並可能導致接種疫苗的禽群死亡率高達 10.0% 至 40.0%（印度報告）。此類案例加劇了農民的疑慮，並限制了疫苗的普及。

市場機會與趨勢

政府主導的疫苗接種活動蘊藏著巨大的商機。例如，2025 年 4 月，印度畜牧和乳業部 (DAHD) 與家禽業合作進行高致病性禽流感 (HPAI) 疫苗接種活動，展現了政府為確保糧食安全而採取的積極舉措。這些措施將有助於縮小免疫差距，尤其是在小農戶群體中，並支持家禽疫苗市場的擴張。

一個值得關注的產業趨勢是向卵內疫苗接種技術的轉變。這項技術允許在孵化第18天將疫苗直接注入雞蛋。這種方法能使雛雞早期獲得免疫力，減少人工成本，並消除傳統皮下或眼部給藥方式所帶來的壓力反應。領先企業正在加速研發卵內給藥疫苗。例如，HIPRA於2022年10月在歐洲推出了卵內球蟲病疫苗 "EVANOVO" 。

市場區隔分析

依技術分類

在2024年，滅活疫苗區隔市場佔主導地位，這主要得益於疾病爆發的增加和對家禽食品安全需求的增長。 2025年2月，Zoetis Services LLC的禽流感疫苗（H5N2亞型）等關鍵產品的上市進一步鞏固了這個區隔市場。

依疾病類型劃分

2024年，病毒性疾病疫苗佔了最大的市場佔有率，這反映了禽流感、新城疫和馬立克氏症日益增長的威脅。主要行業參與者正專注於病毒疫苗，以確保家禽群的生物安全。

依給藥途徑劃分

由於其劑量控制精準且免疫反應強，腸外給藥途徑在2024年仍占主導地位。默克公司（Merck & Co. Inc.）的雞用肌肉注射疫苗NOBILIS MULTRIVA REOm於2024年3月獲得歐洲市場核准上市。

依通路劃分

在政府積極政策和獸醫廣泛支持下，獸醫診所在2024年佔了最大的市場佔有率。例如，南非於2025年6月啟動了針對高致病性禽流感（HPAI）的大規模疫苗接種運動。

區域展望

北美

在監管合規、強勁的家禽生產和研發資金的推動下，北美將成為2024年最大的區域市場（5.8億美元）。 2025年4月，美國農業部（USDA）撥款1億美元用於禽流感疫苗研究。

歐洲和亞太地區

預計到2025年，歐洲市場規模將達到3.6億美元，這得益於對家禽產品需求的增長以及旨在維護家禽群健康的各項舉措。預計到2025年，亞太地區市場規模將達到1.7億美元，成為全球第三大市場，主要得益於家禽產量的增加和人們健康意識的提高。

拉丁美洲、中東和非洲

預計到2025年，拉丁美洲和中東/非洲地區的市場規模將分別溫和成長1.1億美元和6,000萬美元，主要得益於政府的宣傳活動和醫療保健政策。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢
  • 市場挑戰

第四章：主要發現

  • 主要國家和地區家禽疾病概述（2024 年）
  • 主要國家和地區監管狀況（2024 年）
  • 家禽疾病疫苗接種概述
  • 主要公司新技術應用
  • 主要產業趨勢（併購、合作、等等）

第五章：全球家禽疫苗市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依技術分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測 - 依疾病類型分類
    • 病毒性疾病
      • 禽流感
      • 新城疫
      • 馬立克氏症
      • 其他
    • 細菌性疾病
      • 沙門氏菌病
      • 支原體病
      • 其他
    • 寄生蟲疾病
  • 市場分析、洞察與預測 - 依給藥途徑
    • 腸外給藥
    • 鼻腔給藥
    • 其他
  • 市場分析、洞察與預測 - 依銷售管道
    • 獸醫院
    • 獸醫診所
    • 藥局
    • 其他
  • 市場分析、洞察與預測 - 依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美家禽疫苗市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 美國各州
    • 加拿大

第七章 歐洲家禽疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章 亞太地區家禽疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲家禽疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲家禽疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲國家

第十一章：競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
  • 禮來動保
  • 勃林格殷格翰國際股份有限公司
  • 維克
  • 默克有限公司
  • 碩騰服務有限公司
  • 塞瓦酒
  • Bioveta, a.s.
  • 印度免疫學有限公司
  • 海普拉
Product Code: FBI113875

Growth Factors of poultry vaccines Market

The global poultry vaccines market is witnessing significant growth, driven by increasing demand for poultry products, rising incidence of infectious diseases, and greater awareness of flock health management. The market size was valued at USD 1.27 billion in 2024, is projected to reach USD 1.32 billion in 2025, and is expected to grow to USD 2.01 billion by 2032, representing a steady CAGR of 6.13% during the forecast period. North America dominated the market with a 45.66% share in 2024, owing to stringent regulations, advanced veterinary infrastructure, and the presence of major industry players.

The growing consumption of poultry eggs and meat worldwide is the primary driver for market expansion. According to the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in 2024/2025 in the U.S., accounting for approximately 21.0% of global production. Such high production rates necessitate maintaining disease-free flocks to ensure food security, consistent supply, and high-quality protein. Vaccination serves as a critical tool to prevent outbreaks of diseases such as avian influenza, Newcastle disease, Marek's disease, and infectious bronchitis, thereby protecting economic interests and poultry productivity. In November 2024, Vaxxinova received marketing authorization from the European Commission for Vaxxon ND Clone, a vaccine targeting Newcastle Disease virus, exemplifying the active push for effective immunization.

Market Drivers and Restraints

The market is strongly supported by rising poultry consumption and increasing awareness of biosecurity practices among farmers. Vaccinations not only reduce economic losses but also enhance the overall health and productivity of poultry farms. Additionally, key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH are investing heavily in research and development to produce more effective and affordable vaccines. These strategic initiatives further reinforce market expansion.

However, the global poultry vaccines market faces challenges. Vaccine failures and "leaky" vaccine risks pose a restraint to growth. High mutation rates in poultry pathogens, such as Marek's disease and avian influenza, can reduce vaccine efficacy, leading to mortality rates ranging between 10.0% and 40.0% in vaccinated flocks, as reported in India. Such occurrences increase farmer skepticism and limit vaccine adoption.

Market Opportunities and Trends

Government-led vaccination campaigns present lucrative opportunities. For instance, in April 2025, India's Department of Animal Husbandry & Dairying (DAHD) collaborated with the poultry industry to administer vaccines against Highly Pathogenic Avian Influenza (HPAI), highlighting proactive measures to ensure food security. Such initiatives help bridge immunity gaps, particularly among small-scale farmers, and support the expansion of the poultry vaccines market.

A prominent industry trend is the shift toward in-ovo vaccination technology, which allows vaccines to be administered directly into eggs at day 18 of incubation. This approach provides chicks with early immunity, reduces labor, and eliminates stress associated with traditional subcutaneous or ocular methods. Key players are increasingly launching vaccines designed for in-ovo application. For example, HIPRA introduced EVANOVO in Europe in October 2022, a vaccine targeting coccidiosis for in-ovo administration.

Segmentation Analysis

By Technology

The inactivated vaccines segment dominated the market in 2024, driven by rising disease outbreaks and growing demand for poultry food security. Key launches, such as Zoetis Services LLC's Avian Influenza Vaccine, H5N2 subtype, in February 2025, continue to bolster the segment.

By Disease Type

The viral diseases segment accounted for the largest share in 2024, reflecting increasing threats from avian influenza, Newcastle disease, and Marek's disease. Major industry players are focusing on viral vaccines to ensure flock biosecurity.

By Route of Administration

The parenteral segment remained dominant in 2024 due to precise dose delivery and stronger immune responses. Merck & Co., Inc., received European marketing authorization in March 2024 for NOBILIS MULTRIVA REOm, an intramuscular vaccine for chickens.

By Distribution Channel

Veterinary hospitals held the leading market share in 2024, supported by active government initiatives and widespread veterinary outreach. For instance, South Africa launched a mass vaccination campaign in June 2025 targeting HPAI.

Regional Outlook

North America

The largest regional market in 2024 with USD 0.58 billion, driven by regulatory compliance, strong poultry production, and research funding. The USDA allocated USD 100 million in April 2025 for avian influenza vaccine research.

Europe & Asia Pacific

Europe is expected to reach USD 0.36 billion in 2025, supported by increasing poultry product demand and flock health initiatives. Asia Pacific is projected to attain USD 0.17 billion in 2025, ranking third globally due to expanding poultry production and rising health awareness.

Latin America & Middle East/Africa

Latin America and Middle East/Africa are expected to grow moderately, reaching USD 0.11 billion and USD 0.06 billion, respectively, in 2025, supported by government campaigns and healthcare initiatives.

Competitive Landscape

The market is semi-fragmented, with Zoetis, Merck & Co., Boehringer Ingelheim, Elanco, Ceva, HIPRA, and others actively pursuing strategic collaborations, new product launches, and geographic expansion. Notable developments include Bioveta's launch of an inactivated bacterial vaccine in July 2025 and Virbac's acquisition of Globion in India in October 2023.

With projected growth to USD 2.01 billion by 2032, the global poultry vaccines market is poised for expansion, driven by rising protein demand, technological innovations, government support, and increasing focus on flock health and biosecurity.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Viral Diseases
    • Avian Influenza
    • Newcastle Disease
    • Marek's Disease
    • Others
  • Bacterial Diseases
    • Salmonellosis
    • Mycoplasmosis
    • Others
  • Parasitic Diseases

By Route of Administration

  • Parenteral
  • Intranasal
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Poultry Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Viral Diseases
      • 5.2.1.1. Avian Influenza
      • 5.2.1.2. Newcastle Disease
      • 5.2.1.3. Marek's Disease
      • 5.2.1.4. Others
    • 5.2.2. Bacterial Diseases
      • 5.2.2.1. Salmonellosis
      • 5.2.2.2. Mycoplasmosis
      • 5.2.2.3. Others
    • 5.2.3. Parasitic Diseases
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Poultry Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Viral Diseases
      • 7.2.1.1. Avian Influenza
      • 7.2.1.2. Newcastle Disease
      • 7.2.1.3. Marek's Disease
      • 7.2.1.4. Others
    • 7.2.2. Bacterial Diseases
      • 7.2.2.1. Salmonellosis
      • 7.2.2.2. Mycoplasmosis
      • 7.2.2.3. Others
    • 7.2.3. Parasitic Diseases
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Viral Diseases
      • 8.2.1.1. Avian Influenza
      • 8.2.1.2. Newcastle Disease
      • 8.2.1.3. Marek's Disease
      • 8.2.1.4. Others
    • 8.2.2. Bacterial Diseases
      • 8.2.2.1. Salmonellosis
      • 8.2.2.2. Mycoplasmosis
      • 8.2.2.3. Others
    • 8.2.3. Parasitic Diseases
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Viral Diseases
      • 9.2.1.1. Avian Influenza
      • 9.2.1.2. Newcastle Disease
      • 9.2.1.3. Marek's Disease
      • 9.2.1.4. Others
    • 9.2.2. Bacterial Diseases
      • 9.2.2.1. Salmonellosis
      • 9.2.2.2. Mycoplasmosis
      • 9.2.2.3. Others
    • 9.2.3. Parasitic Diseases
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Viral Diseases
      • 10.2.1.1. Avian Influenza
      • 10.2.1.2. Newcastle Disease
      • 10.2.1.3. Marek's Disease
      • 10.2.1.4. Others
    • 10.2.2. Bacterial Diseases
      • 10.2.2.1. Salmonellosis
      • 10.2.2.2. Mycoplasmosis
      • 10.2.2.3. Others
    • 10.2.3. Parasitic Diseases
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA

List of Tables

  • Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2024